Andrieu S - Search Results

1

Biomarkers for Alzheimer's disease therapeutic trials.

Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, Weiner M, Winblad B, Coley N, Vellas B; Oxford Task Force Group. Hampel H, et al. Among authors: andrieu s. Prog Neurobiol. 2011 Dec;95(4):579-93. doi: 10.1016/j.pneurobio.2010.11.005. Epub 2010 Dec 2. Prog Neurobiol. 2011. PMID: 21130138 Review.

2

[Nursing strategy. Alzheimer's disease, early diagnosis and treatments].

Amouyal-Barkate K, Voisin T, Andrieu S, Nourhashemi F, Vellas B. Amouyal-Barkate K, et al. Among authors: andrieu s. Soins Gerontol. 2002 Jul-Aug;(36):14-21. Soins Gerontol. 2002. PMID: 12154665 French. No abstract available.

3

Cognitive function and caregiver burden: predictive factors for eating behaviour disorders in Alzheimer's disease.

Rivière S, Gillette-Guyonnet S, Andrieu S, Nourhashemi F, Lauque S, Cantet C, Salva A, Frisoni G, Vellas B. Rivière S, et al. Among authors: andrieu s. Int J Geriatr Psychiatry. 2002 Oct;17(10):950-5. doi: 10.1002/gps.724. Int J Geriatr Psychiatry. 2002. PMID: 12325056

4

Different modes of weight loss in Alzheimer disease: a prospective study of 395 patients.

Guérin O, Andrieu S, Schneider SM, Milano M, Boulahssass R, Brocker P, Vellas B. Guérin O, et al. Among authors: andrieu s. Am J Clin Nutr. 2005 Aug;82(2):435-41. doi: 10.1093/ajcn.82.2.435. Am J Clin Nutr. 2005. PMID: 16087990 Free article.

5

Disease-modifying trials in Alzheimer's disease: a European task force consensus.

Vellas B, Andrieu S, Sampaio C, Wilcock G; European Task Force group. Vellas B, et al. Among authors: andrieu s. Lancet Neurol. 2007 Jan;6(1):56-62. doi: 10.1016/S1474-4422(06)70677-9. Lancet Neurol. 2007. PMID: 17166802 Review.

6

Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease.

Helmer C, Andrieu S, Pérès K, Orgogozo JM, Vellas B, Dartigues JF; REAL.fr Group. Helmer C, et al. Among authors: andrieu s. Dement Geriatr Cogn Disord. 2007;23(3):168-74. doi: 10.1159/000098516. Epub 2007 Jan 11. Dement Geriatr Cogn Disord. 2007. PMID: 17215578

7

Response to letter from Garcia and colleagues on cholinesterase inhibitors and Alzheimer's disease outcomes.

Gillette-Guyonnet S, Andrieu S, Nourhashemi F, Reynish E, Vellas B. Gillette-Guyonnet S, et al. Among authors: andrieu s. J Gerontol A Biol Sci Med Sci. 2007 Jun;62(6):679-80. doi: 10.1093/gerona/62.6.679. J Gerontol A Biol Sci Med Sci. 2007. PMID: 17595427 No abstract available.

8

Special acute care unit for older adults with Alzheimer's disease.

Soto ME, Nourhashemi F, Arbus C, Villars H, Balardy L, Andrieu S, Vellas B. Soto ME, et al. Among authors: andrieu s. Int J Geriatr Psychiatry. 2008 Feb;23(2):215-9. doi: 10.1002/gps.1865. Int J Geriatr Psychiatry. 2008. PMID: 17645281

9

A 2-year follow-up of 233 very mild (CDR 0.5) Alzheimer's disease patients (REAL.FR cohort).

Nourhashémi F, Ousset PJ, Gillette-Guyonnet S, Cantet C, Andrieu S, Vellas B; REAL.FR cohort. Nourhashémi F, et al. Among authors: andrieu s. Int J Geriatr Psychiatry. 2008 May;23(5):460-5. doi: 10.1002/gps.1904. Int J Geriatr Psychiatry. 2008. PMID: 17894422

10

Endpoints for trials in Alzheimer's disease: a European task force consensus.

Vellas B, Andrieu S, Sampaio C, Coley N, Wilcock G; European Task Force Group. Vellas B, et al. Among authors: andrieu s. Lancet Neurol. 2008 May;7(5):436-50. doi: 10.1016/S1474-4422(08)70087-5. Lancet Neurol. 2008. PMID: 18420157 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

491 results

Search Page

Filters